ECP
QDEL icon

Empyrean Capital Partners’s QuidelOrtho QDEL Stock Holding History

Empyrean Capital Partners’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-135,500
Closed -$15.2M – 167
2022
Q1 		$15.2M Hold
135,500
– – 0.34% 77
2021
Q4 		$18.3M Buy
+135,500
New +$18.9M 0.49% 60

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Empyrean Capital Partners's QDEL Position: Q2 2022 in Review

Empyrean Capital Partners sold out of QuidelOrtho (QDEL) in Q2 2022, closing a stake of 135,500 shares — an estimated $15.2M sold.

Empyrean Capital Partners first reported a position in QDEL in Q4 2021 and held it in 2 quarters. The position peaked at $18.3M in Q4 2021. 347 funds tracked by Wall St. Rank hold QDEL as of Q2 2022.

  • Empyrean Capital Partners reported no remaining QuidelOrtho position as of Q2 2022 after selling out during the quarter.
  • Empyrean Capital Partners sold 135,500 QuidelOrtho shares in Q2 2022, an estimated $15.2M.
  • Empyrean Capital Partners first reported a position in QuidelOrtho in Q4 2021 and held it in 2 quarters.
  • Empyrean Capital Partners's QuidelOrtho position peaked at $18.3M in Q4 2021.
  • 347 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.